NCT07042256View on ClinicalTrials.gov

Feasibility of MR-Informed Adaptive Marker-less SBRT in Patients With Bilateral Hip Prostheses Undergoing SBRT for Localized Prostate Cancer

NANot yet recruitingINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

September 30, 2028

Study Completion Date

September 30, 2028

Conditions
Localized Prostate Adenocarcinoma
Interventions
RADIATION

Low-field MR-informed adaptive marker-less SBRT for definitive treatment of localized prostate cancer in patients with bilateral hip prostheses

Low-field MR-informed adaptive marker-less SBRT

All Listed Sponsors
lead

University of Zurich

OTHER

NCT07042256 - Feasibility of MR-Informed Adaptive Marker-less SBRT in Patients With Bilateral Hip Prostheses Undergoing SBRT for Localized Prostate Cancer | Biotech Hunter | Biotech Hunter